A computational assay to design an epitope-based peptide vaccine against saint louis encephalitis virus

Bioinformatics and Biology Insights

Volumn 7, Issue , 2013, Pages 347-355

  Hasan, Md Anayet ^a   Hossain, Mehjabeen ^a   Alam, Md Jibran ^a  

^a UNIVERSITY OF CHITTAGONG   (Bangladesh)

Author keywords

Cell mediated immunity; Computational tools; Conservancy; Epitope; Humoral

Indexed keywords

AMINO ACID; ENVELOPE PROTEIN; EPITOPE; HLA ANTIGEN; PEPTIDE VACCINE;

AMINO ACID SEQUENCE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; COMPUTER MODEL; HLA SYSTEM; MOLECULAR DOCKING; NONHUMAN; PROTEIN DATABASE; PROTEIN SECONDARY STRUCTURE; SEQUENCE ANALYSIS; SIMULATION; ST LOUIS FLAVIVIRUS;

FLAVIVIRIDAE; RNA VIRUSES; ST. LOUIS ENCEPHALITIS VIRUS;

EID: 84888393761     PISSN: None     EISSN: 11779322     Source Type: Journal    
DOI: 10.4137/BBI.S13402     Document Type: Article

References (49)

1. Kramer LD, Presser SB, Hardy JL, Jackson AO. Genotypic and phenotypic variation of selected Saint Louis encephalitis viral strains isolated in California. Am J Trop Med Hyg. 1997;57(2):222-9.
2. Reisen WK. Epidemiology of St. Louis encephalitis virus. Adv Virus Res. 2003;61:139-83.
3. Shaman J, Day JF, Stieglitz M, et al. Seasonal forecast of St. Louis encephalitis virus transmission, Florida. Emerg Infect Dis. 2004;10(5):802-9.
4. Sejvar JJ, Bode AV, Curiel M, et al. Post-infectious encephalomyelitis associated with St. Louis encephalitis virus infection. Neurology. 2004;63(9):1719-21.
5. Reimann CA, Hayes EB, Guiseppi DC, et al. Epidemiology of neuroinvasive arboviral disease in the United States, 1999-2007. Am J Trop Med Hyg. 2008;79(6):974-9.
6. Rahal JJ, Anderson J, Rosenberg C, Reagan T, Thompson LL. Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study. J Infect Dis. 2004;190(6):1084-7.
7. Trent DW, Qureshi AA. Structural and nonstructural proteins of Saint Louis encephalitis virus. Journal of Virology. 1971;7(3):379-88.
8. Testa JS, Philip R. Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications. Future virol. 2012;7(11):1077-1088.
9. Seib KL, Dougan G, Rappuoli R. The key role of genomics in modern vaccine and drug design for emerging infectious diseases. Plos Genetics. 2009;5(10):e1000612.
10. Hammer J, Gallazzi F, Bono E, et al. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med. 1995;181(5):1847-55.
11. Saha S, Raghava GP. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins. 2006;65(1):40-8.
12. Segal NH, Parsons DW, Peggs KS, et al. Epitope landscape in breast and colorectal cancer. Cancer Res. 2008;68(3):889-92.
13. Stassar MJ, Raddrizzani L, Hammer J, et al. T-helper cell-response to MHC class II-binding peptides of the renal cell carcinoma-associated antigen RAGE-1. Immunobiology. 2001;203(5):743-55.
14. Bourdette DN, Edmonds E, Smith C, et al. A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis. Mult Scler. 2005;11(5):552-61.
15. Lopez JA, Weilenman C, Audran R, et al. synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies. Eur J Immunol. 2001;31(7):1989-98.
16. Knutson KL, Schiffman K, Disis ML. Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients. J Clin Invest. 2001;107(4):477-84.
17. Petrovsky N, Brusic V. Computational immunology: The coming of age. Immunol Cell Biol. 2002;80(3):248-54.
18. Brusic V, Bajic VB, Petrovsky N. Computational methods for prediction of T-cell epitopes-a framework for modelling, testing, and applications. Methods. 2004;34(4):436-43.
19. Peters B, Bulik S, Tampe R, et al. Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. J Immunol. 2003;171(4):1741-9.
20. Bhasin M, Raghava GP. Analysis and prediction of affinity of TAP binding peptides using cascade SVM. Protein Sci. 2004;13(5):596-607.
21. Nielsen M, Lundegaard C, Lund O, Kesmir C. The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Immunogenetics. 2005;57(1-2):33-41.
22. Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics. 2007;8(4).
23. Geourjon C, Deleage G. SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput Appl Biosci. 1995;11(6):681-4.
24. Larsen MV, Lundegaard C, Lamberth K, et al. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics. 2007;8:424.
25. Buus S, Lauemøller SL, Worning P, et al. Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens. 2003;62(5):378-84.
26. Lundegaard C, Nielsen M, Lund O. The validity of predicted T-cell epitopes. Trends Biotechnol. 2006;24(12):537-8.
27. Moutaftsi M, Peters B, Pasquetto V, et al. A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat Biotechnol. 2006;24(7):817-9.
28. Gras S, Kedzierski L, Valkenburg SA, et al. Cross reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1 N1-1918 influenza A viruses. Proc Natl Acad Sci USA. 2010;107(28):12599-604.
29. Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem. 2010;31(2):455-61.
30. Deepak N, Singh K, Siddiqui Z, Nayak B, et al. Epitope recognition by diverse antibodies suggests conformational convergence in an antibody response. J Immunol. 2002;168(5):2371-82.
31. Fieser TM, John A, Tainer H, et al. Influence of protein flexibility and peptide conformation on reactivity of monoclonal anti-peptide antibodies with a protein a-helix. Proc Natl Acad Sci. 1987;84(23):8568-72.
32. Kolaskar AS, Tongaonkar PC. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 1990;276(1-2):172-4.
33. Emini EA, Hughes JV, Perlow DS, et al. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol. 1985;55(3):836-9.
34. Parker JM, Guo D, Hodges RS. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry. 1986;25(19):5425-32.
35. Karplus PA, Schulz GE. Prediction of chain flexibility in proteins. Naturwissenschaften. 1985;72:212-3.
36. Andersen PH, Nielsen M and Lund O. Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. Protein Sci. 2006;15(11):2558-67.
37. Rini JM, Schulze-Gahmen U, Wilson IA. Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science 1992;255(5047):959-65.
38. Chou PY, Fasman GD. Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol. 1978;47:45-148.
39. Roehrig JT, Mathews JH, Trent DW. Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology. 1983;128(1):118-26.
40. Singh S, Taneja B, Salvi SS, Agrawal A. Physical properties of intact proteins may predict allergenecity or lack thereof. PLoS One. 2009;4(7):e6273.
41. Robson B, Pain RS. Analysis of the code relating sequence to conformation in globular proteins, the distribution of residue pairs in turns and kinks in the backbone chain. Biochem J, 1974;141(3):899-904.
42. Blythe MJ, Flower DR. Benchmarking B cell epitope prediction: underperformance of existing methods. Protein Science. 2009;14(1):246-8.
43. Venugopal K, Jiang WR, Gould EA. Immunity to St. Louis encephalitis virus by sequential immunization with recombinant vaccinia and baculovirus derived PrM/E proteins. Vaccine. 1995;13(11):1000-5.
44. Shrestha B, Diamond MS. Role of CD8+ T cells in control of West Nile virus infection. J Virol. 2004;78(15):8312-21.
45. Tan PT, Khan AM, August JT. Highly conserved influenza A sequences as T cell epitopes-based vaccine targets to address the viral variability. Hum. Vaccine. 2011;7(4),402-9.
46. Trainor NB, Crill WD, Roberson JA, et al. Mutation analysis of the fusion domain region of St. Louis encephalitis virus envelope protein. Virology. 2007;360(2):398-406.
47. Klavinskis LS, Whitton JL, Oldstone MB. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection. J Virol. 1989,63(10):4311-6.
48. Sette S, Sidney J. Nine major HLA Class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics. 1999;50(3-4):210-2.
49. Middleton D, Menchaca L, Rood H, et al. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens. 2003;61(5):403-7.